Mangalam Drugs & Organics Limited

NSE:MANGALAM.NS

127.32 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 3,685.9483,701.9544,473.6723,799.2812,822.1172,239.4842,758.8883,028.8562,950.2182,205.8391,223.1971,252.5871,531.8191,313.5551,122.9221,024.03949.99
Cost of Revenue 2,982.3432,506.4363,111.9582,558.4251,984.2931,552.2561,655.822,220.7952,286.741,797.481959.8281,125.6761,227.7231,130.123972.269894.263851.695
Gross Profit 703.6051,195.5181,361.7141,240.856837.824687.2281,103.068808.061663.478408.358263.369126.911304.096183.432150.653129.76798.295
Gross Profit Ratio 0.1910.3230.3040.3270.2970.3070.40.2670.2250.1850.2150.1010.1990.140.1340.1270.103
Reseach & Development Expenses 033.15729.64722.53220.84737.15732.0410.24712.8197.9237.519.34200000
General & Administrative Expenses 092.49877.69758.86272.45964.19472.39662.86972.02933.0424.75343.3551.4335.67928.56825.53220.715
Selling & Marketing Expenses 061.91472.94275.18846.5234.56842.126.59659.12354.67434.58931.59821.72322.33815.36713.39113.657
SG&A 676.147154.412150.639134.05118.97998.762114.51662.869131.15287.71459.34274.94873.15358.01743.93538.92334.372
Other Expenses 0.984.3560.3443.5552.7791.4891.7540.431186.631149.796138.159110.389117.92126.78325.05222.12218.508
Operating Expenses 676.1471,050.2231,007.071798.876682.529660.777700.224363.737330.602245.433205.011194.679191.07484.868.98761.04552.88
Operating Income 27.458149.651388.054441.98155.29526.451402.844444.324332.876162.92558.358-67.768113.02298.63281.66668.72245.415
Operating Income Ratio 0.0070.040.0870.1160.0550.0120.1460.1470.1130.0740.048-0.0540.0740.0750.0730.0670.048
Total Other Income Expenses Net -138.19-127.513-110.724-46.789-92.774-83.822-109.372-110.5-92.716-102.837-97.421-100.224-101.643-68.593-59.636-53.738-35.236
Income Before Tax -110.73222.138277.33395.19162.521-57.371293.472333.824240.1660.088-39.063-167.99211.37930.03922.0314.98410.179
Income Before Tax Ratio -0.030.0060.0620.1040.022-0.0260.1060.110.0810.027-0.032-0.1340.0070.0230.020.0150.011
Income Tax Expense -20.0159.43880.755115.482-20.00422.93894.57696.85579.829-1.324-8.671-49.9985.0425.83.82.31.602
Net Income -90.71712.7196.575279.70982.525-80.309198.896236.969160.33161.412-30.392-117.9946.33724.23918.2312.6848.577
Net Income Ratio -0.0250.0030.0440.0740.029-0.0360.0720.0780.0540.028-0.025-0.0940.0040.0180.0160.0120.009
EPS -5.730.812.4217.675.21-5.0712.5714.0711.154.66-2.31-8.950.481.581.380.960.65
EPS Diluted -5.730.812.4217.675.21-5.0712.5714.0710.134.66-2.31-8.950.481.581.380.960.65
EBITDA 173.966259.54450.888550.888209.16678.764438.748463.661347.649171.58398.463-28.371150.386131.362113.79596.9870.834
EBITDA Ratio 0.0470.070.1010.1450.0740.0350.1590.1530.1180.0780.08-0.0230.0980.10.1010.0950.075